Found: 67
Select item for more details and to access through your institution.
Hyperglycaemia following immune checkpoint inhibitor therapy—Incidence, aetiology and assessment.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 4, p. 1, doi. 10.1111/dme.15053
- By:
- Publication type:
- Article
Time Trends in the Outcome of Elderly Patients with Breast Cancer.
- Published in:
- Breast Journal, 2008, v. 14, n. 2, p. 158, doi. 10.1111/j.1524-4741.2007.00547.x
- By:
- Publication type:
- Article
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene.
- Published in:
- Carcinogenesis, 2004, v. 25, n. 3, p. 369
- By:
- Publication type:
- Article
Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma.
- Published in:
- Drugs, 2021, v. 81, n. 9, p. 971, doi. 10.1007/s40265-021-01506-0
- By:
- Publication type:
- Article
Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.
- Published in:
- Drugs, 2017, v. 77, n. 8, p. 813, doi. 10.1007/s40265-017-0732-2
- By:
- Publication type:
- Article
Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0270950
- By:
- Publication type:
- Article
Re: Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 24, p. 1855, doi. 10.1093/jnci/dji445
- By:
- Publication type:
- Article
Re: Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis.
- Published in:
- 2005
- By:
- Publication type:
- Letter
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 2, p. 161, doi. 10.1038/s41416-022-02107-8
- By:
- Publication type:
- Article
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions.
- Published in:
- Oncology, 2016, v. 90, n. 5, p. 280, doi. 10.1159/000444928
- By:
- Publication type:
- Article
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
- Published in:
- Oncologist, 2022, v. 27, n. 4, p. 255, doi. 10.1093/oncolo/oyac022
- By:
- Publication type:
- Article
Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. e306, doi. 10.1002/onco.13586
- By:
- Publication type:
- Article
Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Atezolizumab‐induced linear IgA bullous dermatosis.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 6, p. e193, doi. 10.1111/bjd.21653
- By:
- Publication type:
- Article
Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0025164
- By:
- Publication type:
- Article
Hyperprogression with immunotherapy: Is it real?
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 8, p. 1218, doi. 10.1002/cncr.31997
- By:
- Publication type:
- Article
Hyperprogression with immunotherapy: Is it real?
- Published in:
- 2019
- By:
- Publication type:
- editorial
Durable response of multiple myeloma and non‐small cell lung cancer with simultaneous, biologically targeted treatment.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 1, p. e1, doi. 10.1111/bjh.16393
- By:
- Publication type:
- Article
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30908-1
- By:
- Publication type:
- Article
Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2014, v. 7, p. 285, doi. 10.2147/PGPM.S55339
- By:
- Publication type:
- Article
Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 3, p. 201, doi. 10.1177/1758834016687262
- By:
- Publication type:
- Article
The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2015, v. 9, n. 3, p. 97, doi. 10.1177/1753465815577738
- By:
- Publication type:
- Article
Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 13, p. 2383, doi. 10.1002/cncr.28089
- By:
- Publication type:
- Article
Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Integrated genomics point to immune vulnerabilities in pleural mesothelioma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-98414-w
- By:
- Publication type:
- Article
Y disruption, autosomal hypomethylation and poor male lung cancer survival.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91907-8
- By:
- Publication type:
- Article
Chemotherapy-induced bowel obstruction in small cell lung cancer: a case report.
- Published in:
- Medical Oncology, 2012, v. 29, n. 4, p. 2623, doi. 10.1007/s12032-011-0150-3
- By:
- Publication type:
- Article
Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice.
- Published in:
- BMC Research Notes, 2015, v. 8, p. 1, doi. 10.1186/s13104-015-1675-x
- By:
- Publication type:
- Article
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186106
- By:
- Publication type:
- Article
A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-207
- By:
- Publication type:
- Article
Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance.
- Published in:
- BMC Cancer, 2006, v. 6, p. 150, doi. 10.1186/1471-2407-6-150
- By:
- Publication type:
- Article
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.834704
- By:
- Publication type:
- Article
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 87, doi. 10.2147/LCTT.S463429
- By:
- Publication type:
- Article
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 8, p. 1011, doi. 10.1007/s40273-023-01281-8
- By:
- Publication type:
- Article
Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 450, doi. 10.3390/cancers16020450
- By:
- Publication type:
- Article
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5326, doi. 10.3390/cancers15225326
- By:
- Publication type:
- Article
A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show 18 F-Fluorothymidine "Flare" on Positron Emission Tomography.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3718, doi. 10.3390/cancers15143718
- By:
- Publication type:
- Article
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225509
- By:
- Publication type:
- Article
Updates in Management of Malignant Pleural Mesothelioma.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 12, p. 1758, doi. 10.1007/s11864-023-01148-2
- By:
- Publication type:
- Article
Resolution of severe hyponatraemia is associated with improved survival in patients with cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1156-6
- By:
- Publication type:
- Article
A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-674
- By:
- Publication type:
- Article
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article